Clinical Trial Update: Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial) [Phase 4]

View source ↗

Summary

A Phase 4 trial (TAYSIDE) evaluating metformin in insulin-resistant left ventricular dysfunction associated with congestive heart failure has completed, and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Insulin Resistance

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Dundee | Conditions: Congestive Heart Failure, Insulin Resistance | Phase 4 | Status: COMPLETED | Results posted: 2013-06-06